GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Ending Cash Position

Addex Therapeutics (XSWX:ADXN) Ending Cash Position : CHF3.87 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics Ending Cash Position?

Addex Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 was CHF3.87 Mil.

Addex Therapeutics's quarterly Ending Cash Position declined from Jun. 2023 (CHF7.17 Mil) to Sep. 2023 (CHF4.75 Mil) and declined from Sep. 2023 (CHF4.75 Mil) to Dec. 2023 (CHF3.87 Mil).

Addex Therapeutics's annual Ending Cash Position declined from Dec. 2021 (CHF20.49 Mil) to Dec. 2022 (CHF6.96 Mil) and declined from Dec. 2022 (CHF6.96 Mil) to Dec. 2023 (CHF3.87 Mil).

Addex Therapeutics Ending Cash Position Historical Data

The historical data trend for Addex Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Ending Cash Position Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.54 18.70 20.49 6.96 3.87

Addex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.96 5.60 7.17 4.75 3.87

Addex Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Addex Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=6.956+-3.091
=3.87

Addex Therapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=4.753+-0.888
=3.87

Addex Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Addex Therapeutics (XSWX:ADXN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Ending Cash Position
Comparable Companies
XSWX:RLF XSWX:EVE XSWX:KNRS XSWX:SPEX OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX
Traded in Other Exchanges
ADXN:USA ADXNz:UK APE1:Germany
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Website
https://www.addextherapeutics.com
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Thinking about buying stock in Applovin, Sonos, WiMi Hologram Cloud, Addex Therapeutics, or Snap?

By PRNewswire PRNewswire • 02-09-2023

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire • 02-24-2021